Monographs & Whitepapers
At the Bedside With the Signia™ Stapling System in Bariatric Surgery
Robotic-assisted surgery with its built-in stapling arm has proliferated in bariatric surgery. However, some surgeons prefer to use a handheld manual or energy-powered device, rather than the stapling arm of a robotic platform. In this article, 2 experienced bariatric surgeons discuss the value of joining the benefits of robotic-assisted surgery with the most advanced bedside stapler available.
JUNE 17, 2025
Transforming Surgery With the Da Vinci 5 Robotic System
In this Special Report, 4 experienced surgeons discuss their respective journeys with da Vinci surgery. They explain how they have leveraged the Intuitive ecosystem, integrated intelligence, and advanced instrumentation to enable minimally invasive surgery (MIS) at their institutions and how the enhancements of the most recent iteration of the da Vinci surgical system—da Vinci 5—could further refine MIS.
JANUARY 14, 2025
The NOPAIN Act: Clinical and Financial Opportunities in Hospital Outpatient and Ambulatory Settings
This monograph features the clinical perspectives from those working in the trenches of postsurgical pain management, and addresses how their institutions are preparing for a new separate Medicare reimbursement for certain branded non-opioid analgesics for procedures in the hospital outpatient and ambulatory settings.
OCTOBER 14, 2024
SONICBEAT™ Ultrasonic Dissector in Colorectal Surgery: Dissection, Grasping, and Cutting Precision
In laparoscopic surgery for the management of both benign and malignant colorectal conditions, optimal visualization and precise dissection in the correct anatomic plane are the keys to success for the surgeon to avoid accidental damage to vital structures. Designed to provide fast, easy tissue dissection, stronger tip grasping force, and faster cutting than other 5-mm ultrasonic energy devices, the SONICBEAT™ ultrasonic dissector from Olympus® has been in use for more than 10 years with surgeons performing complex colorectal procedures. This article review relevant clinical experience using the SONICBEAT™ device, highlighting the combination of cutting for colon mobilization and fine dissection for the layer-specific dissection of the mesocolon in the deep pelvis offered by the device.
AUGUST 20, 2024
Heparin Resistance as a Potential Indicator of Acquired and Hereditary Antithrombin Deficiency
Low levels of functional antithrombin impair normal inhibition of the coagulation cascade, leading to an increased risk for venous thromboembolism. Antithrombin deficiency also contributes to heparin resistance, which may be the first indicator of antithrombin deficiency. This Special Report seeks to illuminate the relationship between anticoagulants and the coagulation cascade and underscore the need for careful patient management in the setting of heparin resistance.
MAY 1, 2024
SONICBEAT™ Device—The Precise Ultrasonic Dissector: Utility in Bariatric Surgery
Despite advances introduced over the years, the need for optimal bariatric and metabolic surgical techniques remains. To meet this need, the surgical energy portfolio by Olympus®—which includes the SONICBEAT™ ultrasonic dissector and tools within the THUNDERBEAT™ hybrid energy devices—aims to provide surgeons with precise and effective device options when performing these potentially complex procedures. This article reviews specific features of the SONICBEAT device designed for utility in bariatric surgery as well as provides the perspective of a clinician using the device in complex revisional surgery, sleeve gastrectomy/Roux-en-Y procedures, and other procedures in bariatric surgery.
APRIL 26, 2024
Clinical Efficacy and Technical Benefits When Using the THUNDERBEAT™ Advanced Energy Open Portfolio in Thyroidectomy and Breast Surgery
Surgeons performing head and neck as well as breast procedures have turned to bipolar and ultrasonic energy devices to provide effective vessel cutting and sealing. However, use of these devices separately can lead to instrument exchange and surgical inefficiency. By combining the availability of both energy sources in one ergonomic device, the Olympus® THUNDERBEAT™ Open Fine Jaw Type X device and THUNDERBEAT™ Type S device can provide the benefits related to the 2 sources of energy and offer dissection and sealing of vessels up to and including 7 mm in diameter. This article reviews how each device has been designed to improve efficacy and the overall clinical experience.
APRIL 3, 2024
Intravenous Ibuprofen for the Treatment of Pain and Fever: An Update
Intravenous ibuprofen (IVIB; Caldolor®) has been studied extensively in a variety of clinical areas and has emerged as a safe and effective alternative to other nonsteroidal anti-inflammatory drugs. This Special Report evaluates the current data supporting the use of IVIB as a standard of care for the treatment of pain and fever in adult and pediatric patients.
FEBRUARY 16, 2024
Da Vinci to the Rescue: Advancing Minimally Invasive Surgery in Elective and Emergency Settings
In this Special Report, 3 expert robotic-assisted surgeons discuss the advantages of the da Vinci® system's enhanced surgical field visualization and wristed instruments and how Intuitive Surgical's integrated intelligence and unified ecosystem data can help optimize decision making. They describe recent after-hours cases in which they used the da Vinci Xi® surgical system, preventing an open procedure and allowing a faster discharge.
JANUARY 4, 2024
The Future of Robotic Surgery
At the 2023 meeting of the Society of American Gastrointestinal and Endoscopic Surgeons in Montréal, Canada, Dr Namir Katkhouda led a live educational setting about emerging trends in robotic-assisted surgery. Faculty experts discussed the tools they use to improve outcomes and workflow in their practices and shared their views on a transforming surgical landscape.
OCTOBER 5, 2023
A Celecoxib and Tramadol Hydrochloride Co-crystal Formulation for the Management of Acute Pain
This monograph reviews the updated CDC recommendations on the management of acute pain, highlighting the availability of a celecoxib and tramadol hydrochloride co-crystal (CTC) formulation to address the gap in treating patients with acute pain that is severe enough for opioid therapy. Cases depicting patients experiencing acute pain who are treated with CTC in the office and surgical settings are included to outline the complexities of managing these patients.
JULY 6, 2023
The Impact of COVID-19: Migrating Procedures to Outpatient Surgery
This article is based on a symposium held at the 2022 Clinical Congress of the American College of Surgeons, and describes the use of enhanced recovery protocols and implementation of a multimodal analgesic approach, with liposomal bupivacaine as a key component, in minimizing opioid use in the wake of the migration of various types of surgery, including colorectal and breast procedures, to the outpatient setting.
JUNE 5, 2023
